COMMUNIQUÉS West-GlobeNewswire

Aveanna Healthcare Holdings Announces Updated Full Year 2025 and Initial Full Year 2026 Guidance
14/01/2026
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today [...]
LENZ Therapeutics and Sarah Jessica Parker announce the launch of “Make it VIZZable”, the VIZZ consumer campaign
14/01/2026
Struggling to see up close? VIZZ is a revolutionary, once-daily eye drop and alternative to reading glasses to restore near vision for up to 10 hours The “ Make it VIZZable ” campaign features SJP enjoying the everyday [...]
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
14/01/2026
Supports capital-efficient expansion of the SLS009 clinical program into frontline AML, enabling broader U.S. and European patient enrollment U.S. enrollment evaluating SLS009 in combination with AZA/VEN in newly [...]
RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026
14/01/2026
CEO Shaun Bagai to Discuss RenovoRx’s Commercial and Clinical Program Progress MOUNTAIN VIEW, Calif., Jan. 14, 2026 (GLOBE NEWSWIRE) -- RenovoRx, Inc. (Nasdaq: RNXT) (“RenovoRx” or “the Company”), a life sciences [...]
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
14/01/2026
TAIPEI, Taiwan & NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SL BIO Ltd. ("SL Bio" or the “Company”), a biomedical company specializing in developing innovative cellular and gene therapies, and Horizon Space [...]
Nanox Expands in Europe with New Nanox.ARC Distribution Engagement in Serbia, Montenegro, and Bosnia and Herzegovina
14/01/2026
Collaboration with Adriamed drives commercial expansion and strengthens Nanox’s regional leadership Engagement supports continued growth across multiple European markets, following recent collaborations in Greece, [...]
Clearmind Medicine Announces Successful Completion of Treatment in All Patients of the Second Cohort in Ongoing Phase I/IIa Clinical Trial for CMND-100
14/01/2026
Vancouver, Canada, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel [...]
COEFFEX AND BEC SEARCH PARTNER TO DELIVER DATA-DRIVEN “WHOLE PERSON” HIRING AND LEADERSHIP DEVELOPMENT TO LIFE SCIENCES AND HEALTHCARE INDUSTRIES
14/01/2026
New collaboration unites executive search, leadership assessment, and coaching to create a measurable competitive advantage through stronger retention and performance OMAHA, NE / COLUMBUS, OH, Jan. 14, 2026 (GLOBE [...]
Alira Health Announces Bill Achtmeyer and George G. Montgomery as Members of Board of Directors
14/01/2026
FRAMINGHAM, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consultancy partnering with life sciences companies and patients to deliver evidence-based solutions, announced that Bill Achtmeyer [...]
J-Star Signs MOU with PSSB to Provide Resins for Batteries
14/01/2026
TAICHUNG CITY, Taiwan, Jan. 14, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions serving diverse [...]
Cannara obtient la qualification OTCQX et annonce la publication de ses résultats financiers du premier trimestre de l'exercice 2026 le 26 janvier 2026
14/01/2026
MONTRÉAL, 14 janv. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous » ou « notre ») ( TSXV : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de produits de [...]
Cannara Achieves OTCQX Qualification and Announces Release of Fiscal Q1 2026 Financial Results on January 26, 2026
14/01/2026
MONTREAL, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, “the Company ”, “ us ” or “ we ”) ( TSXV: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Counslr Expands Long Island Footprint to Support Mental Health in the New Year
14/01/2026
Connecting Students, Faculty, and Community Members to 24/7 Text-Based Support NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Counslr , a leading B2B mental health and wellness platform , announced today new partnerships [...]
Oncolytics Biotech® Appoints John McAdory as EVP of Strategy and Operations and Yujun Wu to Lead Biostatistics
14/01/2026
Appointments strengthen late-stage clinical execution and statistical leadership as the Company advances multiple registration-directed programs in gastrointestinal cancers SAN DIEGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- [...]
Aeroflow Health and Blue Cross Complete of Michigan Partner to Deliver Essential DME to Medicaid Members
14/01/2026
The partnership increases access to critical care supplies such as breast pumps, diapers, and CPAPs for Michigan’s Medicaid population ASHEVILLE, N.C., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Aeroflow Health , a pioneering [...]
Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD
14/01/2026
Four weeks of non-invasive DIFS™ neurostimulation delivers meaningful attention gains alongside objective brain imaging changes HOUSTON, TX, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the [...]
Femasys Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement
14/01/2026
ATLANTA, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY) (“Femasys” or the “Company”), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost- [...]
Adial Pharmaceuticals Announces Publication of International PCT Patent Application to Protect Core Assets and Extend IP Exclusivity to at least 2045
14/01/2026
New patent based on treatment of populations identified to be particularly responsive to ondansetron treatment after examination of Adial’s clinical data and information GLEN ALLEN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE [...]
Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion
14/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE 14 JANUARY 2026 at 16:00 EET Orion updates time estimate for the potential related to the annual Nubeqa® net sales recorded by Orion As the company announced earlier today on 14 [...]

Pages